1. Home
  2. AZTR vs NBY Comparison

AZTR vs NBY Comparison

Compare AZTR & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • NBY
  • Stock Information
  • Founded
  • AZTR 2014
  • NBY 2000
  • Country
  • AZTR United States
  • NBY United States
  • Employees
  • AZTR N/A
  • NBY N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • AZTR Health Care
  • NBY
  • Exchange
  • AZTR Nasdaq
  • NBY Nasdaq
  • Market Cap
  • AZTR 3.2M
  • NBY 2.8M
  • IPO Year
  • AZTR 2023
  • NBY 2007
  • Fundamental
  • Price
  • AZTR $0.25
  • NBY $0.73
  • Analyst Decision
  • AZTR
  • NBY Strong Buy
  • Analyst Count
  • AZTR 0
  • NBY 1
  • Target Price
  • AZTR N/A
  • NBY $0.85
  • AVG Volume (30 Days)
  • AZTR 3.0M
  • NBY 492.7K
  • Earning Date
  • AZTR 03-14-2025
  • NBY 11-07-2024
  • Dividend Yield
  • AZTR N/A
  • NBY N/A
  • EPS Growth
  • AZTR N/A
  • NBY N/A
  • EPS
  • AZTR N/A
  • NBY N/A
  • Revenue
  • AZTR $97,500.00
  • NBY $13,844,000.00
  • Revenue This Year
  • AZTR N/A
  • NBY N/A
  • Revenue Next Year
  • AZTR N/A
  • NBY $17.31
  • P/E Ratio
  • AZTR N/A
  • NBY N/A
  • Revenue Growth
  • AZTR N/A
  • NBY 15.40
  • 52 Week Low
  • AZTR $0.24
  • NBY $0.07
  • 52 Week High
  • AZTR $68.40
  • NBY $6.30
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 36.62
  • NBY 63.10
  • Support Level
  • AZTR $0.24
  • NBY $0.65
  • Resistance Level
  • AZTR $0.65
  • NBY $0.78
  • Average True Range (ATR)
  • AZTR 0.06
  • NBY 0.06
  • MACD
  • AZTR -0.02
  • NBY 0.01
  • Stochastic Oscillator
  • AZTR 1.71
  • NBY 83.07

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Share on Social Networks: